Describe the major types of fungus that cause Mycoses in humans.

Question

Ghissu Editorial · Accepted Answer

Human mycoses are caused by four major fungal groups: Phycomycetes such as Mucor and Rhizopus causing mucormycosis, Ascomycetes such as Aspergillus causing aspergillosis, Basidiomycetes such as Cryptococcus neoformans, and Deuteromycetes such as the dermatophytes Trichophyton and Microsporum. Mucormycosis surged in Andhra Pradesh after COVID-19, driven by steroid use and diabetes.

**Introduction**

Mycoses, fungal infections in humans, have risen notably in immunocompromised patients and during the COVID-19 pandemic. Their diverse fungal origins complicate diagnosis and treatment, especially in regions like ==Andhra Pradesh== where healthcare infrastructure is evolving to address these infections effectively.

**Classification and Biological Features**

SKETCH: tree | Major Fungal Groups Causing Mycoses  
- Phycomycetes  
  - Mucor  
  - Rhizopus  
- Ascomycetes  
  - Aspergillus  
  - Penicillium (rarely pathogenic)  
- Basidiomycetes  
  - Cryptococcus neoformans  
- Deuteromycetes  
  - Trichophyton  
  - Microsporum

2. **Ascomycetes**: Aspergillus species cause aspergillosis, ranging from allergic to invasive forms, prevalent in humid regions like ==Visakhapatnam==. They have septate hyphae and produce ascospores in asci, contributing to their environmental resilience and pathogenicity.

**Clinical and Epidemiological Context**

3. **Basidiomycetes and Deuteromycetes**: Cryptococcus neoformans causes cryptococcosis in HIV/AIDS patients in ==Andhra Pradesh==, often leading to meningitis. Dermatophytes like Trichophyton cause widespread superficial infections such as athlete’s foot and ringworm due to the tropical climate and socio-economic factors promoting transmission.

4. **Regional epidemiology**: Post-COVID-19 mucormycosis cases surged in ==Andhra Pradesh== due to steroid use and diabetes prevalence, affecting sinuses, lungs, and brain. Humid coastal climates increase Aspergillus spore exposure, raising allergic and invasive aspergillosis risk.

**Challenges in Diagnosis and Treatment**

5. **Diagnostic constraints**: Specialized fungal diagnostics like culture, histopathology, and molecular assays are scarce in rural ==Andhra Pradesh==, delaying diagnosis and appropriate treatment initiation.

6. **Therapeutic issues**: Antifungal resistance is emerging, and toxicity of drugs like amphotericin B complicates management, especially in resource-limited settings. Additionally, lack of awareness among healthcare providers delays early detection and worsens outcomes.

**Conclusion**

Recognizing fungal diversity and regional epidemiology is crucial for timely diagnosis and effective treatment of mycoses, particularly in evolving healthcare contexts like ==Andhra Pradesh==.

మానవులలో మైకోసెస్ (Mycoses) కు కారణమయ్యే ప్రధాన రకాల శిలీంధ్రాలను వివరించండి.

Model answer

ఈ ప్రశ్నను ప్రాక్టీస్ చేయండి

మానవ వ్యాధులు; జన్యు ఇంజనీరింగ్ ప్రాథమిక అంశాలు; వ్యవసాయంలో బయోటెక్నాలజీ; టీకాలు54 questions

Ghissu